Health

Results: 13-24 of 6223

PR Newswire associated0

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology

Ping An Good Doctor (1833.HK) Reports Strong Interim Results: Revenue and Profit Accelerate as AI Fuels New Growth Momentum

Driven by athlete feedback, the new Hyperice X 2 unlocks a new era of contrast recovery tech with powerful multi-level compression. With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use.

Hyperice Unveils Next Generation of Contrast Therapy Innovation, Hyperice X 2 Knee and Hyperice X 2 Shoulder

Business Wire logo

Eight Sleep Secures $100 Million to Accelerate AI‑Powered Sleep Optimization, Expand Into Medical, and Grow Global Footprint

PR Newswire associated0

Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma

Business Wire logo

VASTHERA Receives U.S. FDA Clearance to initiate Phase 1 Clinical Trial of Pulmonary Arterial Hypertension Drug Candidate, VTB-10

PR Newswire associated0

Monument Therapeutics Announces Partnership with Foundation for the National Institutes of Health for Clinical Trial of MT1988, a Novel Treatment for Schizophrenia

SciBase: Interim report

PR Newswire associated0

Tigermed Receives MSCI ESG AAA Rating

PR Newswire associated0

CSL announces rise in full year net profit

PR Newswire associated0

Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System